Articles |

The Extracellular Matrix Microenvironment Specifies Pulmonary Endothelial Cell Identity*: Roles of Tenascin-C and RhoA FREE TO VIEW

Lila Sisbarro; Kaori Ihida-Stansbury, PhD; Troy Stevens, PhD; Natalie Bauer; Ivan McMurtry, PhD; Peter Lloyd Jones
Author and Funding Information

*From the Departments of Pediatrics (Ms. Sisbarro, Mr. Ihida-Stansbury, and Mr. Jones) and Medicine (Ms. Bauer and Dr. McMurtry), University of Colorado Health Sciences Center, Denver, CO; and Center for Lung Biology (Dr. Stevens), University of South Alabama, Mobile, AL.

Correspondence to Kaori Ihida-Stansbury, PhD, University of Colorado Health Sciences Center, 4200 E 9th Ave, Room 3432, Box B131, Denver, CO 80262; e-mail: kaori.ihida@UCHSC.edu

Chest. 2005;128(6_suppl):564S. doi:10.1378/chest.128.6_suppl.564S
Text Size: A A A
Published online

Endothelial cells (ECs) from the macrovascular (ie, pulmonary artery) and microvascular (ie, pulmonary capillary) beds are phenotypically and functionally distinct. Consistent with this, pulmonary artery ECs (PAECs) within monocrotaline-treated, hypertensive adult rat lungs interact with an extracellular matrix enriched with tenascin-C, whereas pulmonary microvascular ECs (MVECs) do not. This finding suggests that tenascin-C might contribute to EC heterogeneity within the hypertensive lung. To test this, tenascin-C expression was compared in adult rat PAECs and MVECs cultured on tissue culture plastic, chosen to represent an injured tissue microenvironment. Similar to our in vivo findings, tenascin-C expression was significantly greater in cultured PAECs than in MVECs. Since activated focal adhesion kinase (FAK) is required for expression of Prx1, a homeobox gene transcription factor essential for tenascin-C expression, we next examined and found that levels of activated FAK and Prx1 are also higher in tenascin-C–producing PAECs than in MVECs. Furthermore, inhibition of FAK activity not only reduced Prx1 expression in PAECs, but this also resulted in phenotypic change underscored by disruption of cytocortical F-actin. Since tenascin-C modulates F-actin dynamics through suppression of RhoA, (a small guanosine triphosphatase required for F-actin stress fiber formation), we reasoned that RhoA activity and F-actin distribution would differ in PAECs vs MVECs. Indeed, whereas PAECs possessed lower levels of RhoA activity and exhibited cytocortical F-actin, MVECs had higher levels of RhoA activity and displayed prominent F-actin stress fibers. Finally, to determine whether interactions with tenascin-C directly contribute to pulmonary EC heterogeneity, we cultivated tenascin-C–deficient MVECs on exogenous tenascin-C; this treatment suppressed RhoA activity, an event that was associated with loss of F-actin stress fibers in favor of cytocortical F-actin. Collectively, these data indicate that pulmonary EC heterogeneity observed within the hypertensive lung may depend, in part, on the nature of the surrounding extracellular matrix.

Abbreviations: EC = endothelial cell; FAK = focal adhesion kinase; MVEC = microvascular endothelial cell; PAEC = pulmonary artery endothelial cell




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Engineering de novo assembly of fetal pulmonary organoids. Tissue Eng Part A 2014;20(21-22):2892-907.
Tenascin-C: Form versus function. Cell Adh Migr 2015;9(1-2):48-82.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543